302 related articles for article (PubMed ID: 35150215)
1. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
[TBL] [Abstract][Full Text] [Related]
2. Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate volumes 50-80 mL.
Oumedjbeur K; Corsi NJ; Bouhadana D; Ibrahim A; Nguyen DD; Matta I; Arezki A; Sadri I; Elsherbini T; Bhojani N; Elterman DS; Chughtai B; Helfand BT; Glaser AP; Misrai V; Kaplan S; Gilling P; Barber N; Desai M; Badlani GH; Te AE; Roehrborn CG; Zorn KC
Can J Urol; 2023 Oct; 30(5):11650-11658. PubMed ID: 37838991
[TBL] [Abstract][Full Text] [Related]
3. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
[TBL] [Abstract][Full Text] [Related]
4. Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained.
Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
Adv Ther; 2019 Jun; 36(6):1326-1336. PubMed ID: 31028614
[TBL] [Abstract][Full Text] [Related]
5. Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial.
Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
Can J Urol; 2020 Feb; 27(1):10072-10079. PubMed ID: 32065861
[TBL] [Abstract][Full Text] [Related]
6. Aquablation versus transurethral resection of the prostate: 1 year United States - cohort outcomes.
Kasivisvanathan V; Hussain M
Can J Urol; 2018 Jun; 25(3):9317-9322. PubMed ID: 29900819
[TBL] [Abstract][Full Text] [Related]
7. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes.
Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Roehrborn C
Urology; 2019 Mar; 125():169-173. PubMed ID: 30552937
[TBL] [Abstract][Full Text] [Related]
8. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial.
Plante M; Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
BJU Int; 2019 Apr; 123(4):651-660. PubMed ID: 29862630
[TBL] [Abstract][Full Text] [Related]
9. Aquablation Outcomes in Men With LUTS Due to BPH Following Single Versus Multi-pass Treatments.
Bach T; Barber N; Elterman D; Humphreys M; Bhojani N; Zorn KC; Te A; Chugtai B; Kaplan S
Urology; 2022 Nov; 169():167-172. PubMed ID: 35863498
[TBL] [Abstract][Full Text] [Related]
10. Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates.
Nguyen DD; Barber N; Bidair M; Gilling P; Anderson P; Zorn KC; Badlani G; Humphreys M; Kaplan S; Kaufman R; So A; Paterson R; Goldenberg L; Elterman D; Desai M; Lingeman J; Roehrborn C; Bhojani N
BJU Int; 2020 Jan; 125(1):112-122. PubMed ID: 31599044
[TBL] [Abstract][Full Text] [Related]
11. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation
Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
J Urol; 2018 May; 199(5):1252-1261. PubMed ID: 29360529
[TBL] [Abstract][Full Text] [Related]
12. WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates.
Assad A; Nguyen DD; Barber N; Bidair M; Gilling P; Anderson P; Badlani G; Humphreys M; Kaplan S; Kaufman R; So A; Paterson R; Desai M; Roehrborn C; Chughtai B; Zorn KC; Elterman D; Bhojani N
Urology; 2022 Jul; 165():268-274. PubMed ID: 35469810
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
[TBL] [Abstract][Full Text] [Related]
14. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
[TBL] [Abstract][Full Text] [Related]
15. Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT.
Worthington J; Lane JA; Taylor H; Young G; Noble SM; Abrams P; Ahern A; Brookes ST; Cotterill N; Johnson L; Khan R; Fernandez AM; Page T; Swami S; Hashim H
Health Technol Assess; 2020 Sep; 24(41):1-96. PubMed ID: 32901611
[TBL] [Abstract][Full Text] [Related]
16. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
Gilling P; Reuther R; Kahokehr A; Fraundorfer M
BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
[TBL] [Abstract][Full Text] [Related]
17. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan VM; Dahm P
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD012867. PubMed ID: 35349161
[TBL] [Abstract][Full Text] [Related]
18. Aquablation outcomes for the U.S. cohort of men with LUTS due to BPH in large prostates (80-150 cc).
Yafi FA; Tallman CT; Seard ML; Jordan ML
Int J Impot Res; 2018 Oct; 30(5):209-214. PubMed ID: 30046163
[TBL] [Abstract][Full Text] [Related]
19. Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized study.
Michaelis J; Träger M; Astheimer S; von Büren M; Gabele E; Grabbert M; Halbich J; Kamps M; Klockenbusch J; Noll T; Pohlmann P; Schlager D; Sigle A; Schönthaler M; Wilhelm K; Gratzke C; Miernik A; Schöb DS
World J Urol; 2024 May; 42(1):306. PubMed ID: 38722445
[TBL] [Abstract][Full Text] [Related]
20. Pooled Aquablation Results for American Men with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia in Large Prostates (60-150 cc).
Chughtai B; Thomas D
Adv Ther; 2018 Jun; 35(6):832-838. PubMed ID: 29873008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
